Year archive

MESOBLAST LTD — 2024 filings

All 141 regulatory filings released by MESOBLAST LTD (MESO) in 2024, sourced directly from the official regulator.

141 Filings

2024 Period

2024 filings (141)

Filing	Released	Lang
Regulatory Filings 2024 Regulatory Filings	2024-12-30	English
PROSPECTUS Prospectus	2024-12-27	English
Becoming a substantial holder 18 pages 2.0MB Regulatory Filings	2024-12-26	English
Regulatory Filings 2024 Regulatory Filings	2024-12-23	English
Becoming a substantial holder 33 pages 1.5MB Regulatory Filings	2024-12-23	English
AMENDMENT NO. 1 TO FORM F-3 Regulatory Filings	2024-12-23	English
6-K Foreign Filer Report	2024-12-23	English
6-K Foreign Filer Report	2024-12-20	English
6-K Foreign Filer Report	2024-12-20	English
Cleansing Notice 1 page 234.0KB Regulatory Filings	2024-12-19	English
Application for quotation of securities - MSB 6 pages 19.2KB Regulatory Filings	2024-12-19	English
Appendix 3Y for Eric Rose 3 pages 239.1KB Regulatory Filings	2024-12-19	English
Regulatory Filings 2024 Regulatory Filings	2024-12-18	English
FDA Approves Mesoblast Ryoncil 4 pages 238.3KB Regulatory Filings	2024-12-18	English
Mesoblast Webcast 2 pages 201.9KB Regulatory Filings	2024-12-18	English
Ceasing to be a substantial holder 18 pages 951.6KB Regulatory Filings	2024-12-17	English
Mesoblast to be Added to Nasdaq Biotechnology Index 2 pages 185.6KB Regulatory Filings	2024-12-17	English
AMENDMENT TO FORM SC 13G Major Shareholding Notification	2024-12-16	English
Change in substantial holding 5 pages 228.6KB Regulatory Filings	2024-12-15	English
REGISTRATION STATEMENT Regulatory Filings	2024-12-13	English
6-K Foreign Filer Report	2024-12-09	English
FDA Grants Mesoblast RMAT Designation 3 pages 211.7KB Regulatory Filings	2024-12-04	English
Pause in Trade 1 page 117.7KB Regulatory Filings	2024-12-04	English
Material Announcement 1 page 117.7KB Regulatory Filings	2024-12-04	English
6-K Foreign Filer Report	2024-12-03	English
REVASCOR Improves Survival & Reduces Major Morbidity 3 pages 221.8KB Regulatory Filings	2024-12-02	English
Becoming a substantial holder 35 pages 2.1MB Regulatory Filings	2024-11-20	English
6-K Foreign Filer Report	2024-11-18	English
Mesoblast Chair Message to 2024 AGM 2 pages 189.4KB Regulatory Filings	2024-11-14	English
CEO Presentation to 2024 Annual General Meeting 38 pages 2.5MB Regulatory Filings	2024-11-14	English
Final Director's Interest Notice 2 pages 289.2KB Regulatory Filings	2024-11-14	English
Results of Meeting 3 pages 249.3KB Regulatory Filings	2024-11-14	English
Response to ASX Price Query 4 pages 389.2KB Regulatory Filings	2024-11-13	English
6-K Foreign Filer Report	2024-11-13	English
Notification regarding unquoted securities - MSB 6 pages 20.3KB Regulatory Filings	2024-11-11	English
Warrant Prospectus Related to Convertible Note Agreement 47 pages 746.5KB Regulatory Filings	2024-11-06	English
Ceasing to be a substantial holder 26 pages 1.4MB Regulatory Filings	2024-11-04	English
6-K Foreign Filer Report	2024-11-01	English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 537.9KB Regulatory Filings	2024-10-30	English
6-K Foreign Filer Report	2024-10-18	English
Appendix 4G and Corporate Governance Statement 22 pages 583.4KB Regulatory Filings	2024-10-16	English
Notice of Annual General Meeting and Proxy Form 37 pages 763.1KB Regulatory Filings	2024-10-16	English
Annual Report to Shareholders 258 pages 4.9MB Regulatory Filings	2024-10-16	English
Notification regarding unquoted securities - MSB 6 pages 18.9KB Regulatory Filings	2024-10-10	English
Notification of cessation of securities - MSB 4 pages 14.7KB Regulatory Filings	2024-10-10	English
AMENDMENT TO FORM SC 13G Major Shareholding Notification	2024-10-09	English
Change in substantial holding 5 pages 244.1KB Regulatory Filings	2024-10-09	English
Becoming a substantial holder 28 pages 1.3MB Regulatory Filings	2024-10-08	English
6-K Foreign Filer Report	2024-10-01	English
Mesoblast Option to Issue up to US$50m Convertible Notes 3 pages 208.8KB Regulatory Filings	2024-09-29	English
Proposed issue of securities - MSB 5 pages 18.9KB Regulatory Filings	2024-09-29	English
Ceasing to be a substantial holder 19 pages 1.6MB Regulatory Filings	2024-09-26	English
Becoming a substantial holder 31 pages 1.3MB Regulatory Filings	2024-09-16	English
6-K Foreign Filer Report	2024-08-29	English
20-F Annual Report FY 2024	2024-08-29	English
Preliminary Final Report including Appendix 4E 256 pages 3.1MB Regulatory Filings	2024-08-28	English
Annual Financial Results Presentation 36 pages 2.8MB Regulatory Filings	2024-08-28	English
MSB Annual Financial Results and Operational Update 9 pages 697.7KB Regulatory Filings	2024-08-28	English
Mesoblast 2024 Full Year Financial Results Webcast 1 Regulatory Filings	2024-08-27	English
Class Action Resolution 2 pages 139.2KB Regulatory Filings	2024-08-20	English
6-K Foreign Filer Report	2024-08-01	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 527.1KB Regulatory Filings	2024-07-30	English
6-K Foreign Filer Report	2024-07-25	English
6-K Foreign Filer Report	2024-07-23	English
FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L 3 pages 202.2KB Regulatory Filings	2024-07-22	English
Confirmatory Phase 3 Back Pain Trial Actively Enrols 2 pages 164.2KB Regulatory Filings	2024-07-21	English
Change in substantial holding 4 pages 212.7KB Regulatory Filings	2024-07-11	English
Notification of cessation of securities - MSB 4 pages 14.8KB Regulatory Filings	2024-07-11	English
Notification regarding unquoted securities - MSB 6 pages 19.1KB Regulatory Filings	2024-07-11	English
Appendix 3Y for Philip Krause 2 pages 222.4KB Regulatory Filings	2024-07-11	English
AMENDMENT TO FORM SC 13G Major Shareholding Notification	2024-07-11	English
6-K Foreign Filer Report	2024-07-10	English
Mesoblast Resubmits BLA with FDA for Ryoncil Approval 3 pages 191.3KB Regulatory Filings	2024-07-08	English
6-K Foreign Filer Report	2024-07-02	English
Mesoblast to File BLA for Ryoncil FDA Approval Next Week 2 pages 165.6KB Regulatory Filings	2024-06-30	English
6-K Foreign Filer Report	2024-06-04	English
Corporate Presentation 25 pages 1.8MB Regulatory Filings	2024-06-02	English
Mesoblast Corporate Presentation at Investor Conference 2 pages 165.8KB Regulatory Filings	2024-06-02	English
6-K Foreign Filer Report	2024-05-10	English
Appendix 3Y for Eric Rose 3 pages 242.3KB Regulatory Filings	2024-05-09	English
AMENDMENT TO FORM SC 13G Major Shareholding Notification	2024-05-03	English
6-K Foreign Filer Report	2024-05-03	English
Appendix 3Y for Eric Rose 3 pages 242.1KB Regulatory Filings	2024-05-02	English
Change in substantial holding 4 pages 172.0KB Regulatory Filings	2024-05-01	English
6-K Foreign Filer Report	2024-05-01	English
Mesoblast Chair Transition 2 pages 142.5KB Regulatory Filings	2024-04-29	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 506.4KB Regulatory Filings	2024-04-29	English
PROSPECTUS Prospectus	2024-04-26	English
Regulatory Filings 2024 Regulatory Filings	2024-04-26	English
Regulatory Filings 2024 Regulatory Filings	2024-04-22	English
Regulatory Filings 2024 Regulatory Filings	2024-04-19	English
6-K Foreign Filer Report	2024-04-17	English
6-K Foreign Filer Report	2024-04-17	English
6-K Foreign Filer Report	2024-04-17	English
6-K Foreign Filer Report	2024-04-17	English
REGISTRATION STATEMENT Regulatory Filings	2024-04-16	English
Notification regarding unquoted securities - MSB 6 pages 18.7KB Regulatory Filings	2024-04-15	English
Application for quotation of securities - MSB 7 pages 20.7KB Regulatory Filings	2024-04-15	English
Appendix 3Y for Jane Bell 2 pages 196.3KB Regulatory Filings	2024-04-15	English
Notification of cessation of securities - MSB 4 pages 14.8KB Regulatory Filings	2024-04-14	English
AMENDMENT NO. 1 TO SCHEDULE 13G Major Shareholding Notification	2024-04-09	English
Change in substantial holding 4 pages 2.1MB Regulatory Filings	2024-04-08	English
AMENDMENT NO. 3 TO SCHEDULE 13G Major Shareholding Notification	2024-04-04	English
Change in substantial holding 4 pages 1.1MB Regulatory Filings	2024-04-01	English
6-K Foreign Filer Report	2024-03-26	English
Cleansing Notice 1 page 113.9KB Regulatory Filings	2024-03-25	English
Pause in Trading 1 page 116.4KB Regulatory Filings	2024-03-25	English
FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA 2 pages 167.6KB Regulatory Filings	2024-03-25	English
Application for quotation of securities - MSB 5 pages 16.6KB Regulatory Filings	2024-03-21	English
6-K Foreign Filer Report	2024-03-21	English
AMENDMENT NO. 2 TO SCHEDULE 13G Major Shareholding Notification	2024-03-21	English
Proposed issue of securities - MSB 5 pages 17.2KB Regulatory Filings	2024-03-19	English
Change in substantial holding 4 pages 1.4MB Regulatory Filings	2024-03-19	English
Cleansing Notice 1 page 230.2KB Regulatory Filings	2024-03-18	English
Appendix 2A 20 pages 489.6KB Regulatory Filings	2024-03-17	English
6-K Foreign Filer Report	2024-03-15	English
Mesoblast Completes Placement and Entitlement Offer 2 pages 167.8KB Regulatory Filings	2024-03-13	English
Proposed issue of securities - MSB 5 pages 17.5KB Regulatory Filings	2024-03-13	English
6-K Foreign Filer Report	2024-03-11	English
FDA Supports Accelerated Approval Pathway for Heart Failure 3 pages 196.4KB Regulatory Filings	2024-03-10	English
6-K Foreign Filer Report	2024-03-01	English
6-K Foreign Filer Report	2024-02-29	English
Half Year Report and Accounts (including Appendix 4D) 101 pages 2.0MB Regulatory Filings	2024-02-28	English
Half Year Financial Results Presentation 36 pages 1.9MB Regulatory Filings	2024-02-28	English
MSB Q2 Financial Results and Operational Highlights 8 pages 637.8KB Regulatory Filings	2024-02-28	English
Mesoblast 2024 Half Year Financial Results Webcast 1 Regulatory Filings	2024-02-25	English
6-K Foreign Filer Report	2024-02-20	English
FDA Grants Orphan Drug Designation for Revascor 3 pages 188.6KB Regulatory Filings	2024-02-14	English
6-K Foreign Filer Report	2024-02-01	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 516.2KB Regulatory Filings	2024-01-30	English
6-K Foreign Filer Report	2024-01-23	English
FDA Grants Rare Pediatric Disease Designation for Revascor 3 pages 193.4KB Regulatory Filings	2024-01-18	English
6-K Foreign Filer Report	2024-01-16	English
Notification of cessation of securities - MSB 5 pages 25.8KB Regulatory Filings	2024-01-14	English
Notification regarding unquoted securities - MSB 7 pages 30.8KB Regulatory Filings	2024-01-14	English
App 3Ys S Itescu,E Rose,J Swedish,B Burns,J Bell,P Facchina 13 pages 470.7KB Regulatory Filings	2024-01-14	English
F-6 POS Regulatory Filings	2024-01-05	English
6-K Foreign Filer Report	2024-01-05	English
6-K Foreign Filer Report	2024-01-05	English
Amended Appendix 3Gs for Unquoted Warrants 38 pages 737.4KB Regulatory Filings	2024-01-02	English
Appendix 3Y for Joseph Swedish 2 pages 239.8KB Regulatory Filings	2024-01-02	English

Filings by year

2026 64 filings
2025 202 filings
2024 141 filings
2023 127 filings
2022 135 filings
2021 101 filings
2020 152 filings
2019 117 filings
2018 107 filings
2017 123 filings
2016 97 filings
2015 92 filings
2014 55 filings
2013 53 filings
2012 34 filings
2011 60 filings
2010 63 filings
2009 56 filings
2008 55 filings
2007 48 filings
2006 62 filings
2005 55 filings
2004 14 filings